Author

G. N. Thalmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Assay:organoid / primary culture· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

M. Kruithof-de Julio· 5 shared S. Karkampouna· 4 shared I. Klima· 3 shared E. Zoni· 2 shared F. La Manna· 2 shared M. De Menna· 2 shared M. Kiener· 2 shared M. R. De Filippo· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

M. Kruithof-de Julio

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Identifying drug sensitivity of multifocal primary prostate cancer

J. Kang, P. Chouvardas, K. Ovchinnikova, G. N. Thalmann, S. Karkampouna, M. Kruithof-de Julio

This study uses patient-derived organoids to investigate drug sensitivity in multifocal prostate cancer and develops a transcriptomics-based model to predict drug responses.

bioRxiv · Dec 12, 2023 · PreprintCancer Biology

Mechano-signaling of prostate tumor initiating cells facilitates their tropism to stiff metastatic niche

L. Chen, G. Zhao, M. De Menna, S. Coppola, A. Groenewoud, N. Landman, S. Schieven, G. N. Thalmann, T. Schmidt, J. de Vrie, M. Kruithof-de Julio, E. B. Snaar

The paper shows that mechanotransduction via TAZ and cytoskeletal tension promotes prostate cancer stem cell metastasis and identifies a YAP/TAZ inhibitor as a potential therapeutic target.

bioRxiv · Aug 28, 2023 · PreprintCancer Biology

Bladder cancer organoids as a functional system to model different disease stages and therapy response

M. Minoli, T. Cantore, M. Kiener, T. Fedrizzi, F. La Manna, S. Karkampouna, V. Genitisch, A. Rodriguez, I. Klima, P. Gasperini, B. Kiss, R. Seiler-Blarer, F. Demichelis, G. N. Thalmann, M. Kruithof-de Julio

This study uses bladder cancer patient-derived organoids to model disease stages and therapy response, identifying markers of resistance and sensitivity.

bioRxiv · Mar 31, 2022 · PreprintCancer Biology

Patient-derived xenografts and organoids model therapy response in prostate cancer

S. Karkampouna, F. La Manna, M. R. De Filippo, M. Kiener, M. De Menna, E. Zoni, J. Grosjean, I. Klima, A. Garofoli, M. Bolis, J.-P. Theurillat, V. Genitsch, D. Keller, T. Booij, C. Stirnimann, , M. Kruithof-de Julio

This study develops a patient-derived xenograft (PDX) model of prostate cancer that mimics disease stages and identifies drug sensitivities in metastatic cases.

Nature Communications · Feb 18, 2021Peer-reviewedCancer Biology

Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bonemicroenvironment signatures

S. Karkampouna, M. R. De Filippo, C. Y. Ng, I. Klima, E. Zoni, M. Spahn, F. Stein, P. Haberkant, G. N. Thalmann, M. Kruithof-de Julio

The paper identifies tenascin C as a stromal marker associated with metastasis in prostate cancer xenograft models and shows its prognostic potential in patient samples.

bioRxiv · Apr 3, 2020Cancer Biology